Bg pattern

ELEBLOC 20 mg/ml EYE DROPS SOLUTION

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use ELEBLOC 20 mg/ml EYE DROPS SOLUTION

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the User

ELEBLOC 20mg/ml eye drops solution

Carteolol hydrochloride

Read the entire package leaflet carefully before starting to use this medication, as it contains important information for you.

  • Keep this package leaflet, as you may need to read it again.
  • If you have any questions, consult your doctor or pharmacist.
  • This medication has been prescribed to you only, and you should not give it to others, even if they have the same symptoms of illness as you, as it may harm them.
  • If you experience side effects, consult your doctor or pharmacist, even if they are side effects not listed in this package leaflet. See section 4.

Contents of the package leaflet:

  1. What is Elebloc 20 mg/ml and what is it used for
  2. What you need to know before starting to use Elebloc 20 mg/ml
  3. How to use Elebloc 20 mg/ml
  4. Possible side effects
  5. Storage of Elebloc 20 mg/ml
  6. Package contents and additional information

1. What is Elebloc 20 mg/ml and what is it used for

Elebloc belongs to a group of medications called beta-blockers that contains an active ingredient (carteolol), which acts by decreasing the pressure in the eye (intraocular pressure).

This medication is used in adults to treat increased pressure in the eyes (ocular hypertension) and chronic open-angle glaucoma.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before starting to use Elebloc 20 mg/ml

Do not use Elebloc

  • If you are allergic to carteolol, beta-blockers, or any of the other components of this medication (listed in section 6).
  • If you have or have had respiratory problems such as asthma, severe chronic obstructive bronchitis (a serious lung disease that can cause wheezing, difficulty breathing, and/or long-term coughing).
  • If you have a slow heart rate, heart failure, or heart rhythm disorders (irregular heartbeats).

Warnings and precautions

Consult your doctor or pharmacist before starting to use Elebloc.

Before starting to use this medication, inform your doctor if you have or have had:

  • coronary artery disease (symptoms may include chest pain or discomfort, shortness of breath, or choking), heart failure, low blood pressure.
  • heart rate disorders such as bradycardia (slow heartbeat).
  • respiratory problems, asthma, or chronic obstructive pulmonary disease.
  • poor blood circulation (such as Raynaud's disease or Raynaud's syndrome).
  • diabetes, as carteolol may mask the signs and symptoms of low blood sugar levels.
  • hyperthyroidism, as carteolol may mask the signs and symptoms.

myasthenia gravis (muscle weakness).

Inform your doctor that you are using Elebloc before undergoing surgery, as carteolol may alter the effects of some medications used during anesthesia.

If you use this medication for a long period, your doctor should check you annually to see if treatment failure (loss of medication effectiveness) occurs.

If you experience any severe allergic reaction (skin rash, redness, and itching in the eye) while using this medication, regardless of the cause, treatment with adrenaline may not be as effective. Therefore, when receiving any other treatment, inform your doctor that you are using this medication.

If you have corneal disorders, consult your doctor, as this medication may cause dry eyes.

If you have had glaucoma surgery, consult your doctor before using this medication.

Contact lens users

If you use contact lenses, a possible inhibition of tear production related to this class of medications may pose a risk of intolerance in contact lens users. Also, the preservative used (benzalkonium chloride) may cause eye irritation; it may form a deposit on soft contact lenses and slightly discolor them; therefore, you should not use this eye drop if you wear soft contact lenses. To find out how to apply Elebloc if you wear contact lenses, see the section "Elebloc contains benzalkonium chloride".

Use in elderly patients

This medication should be used with caution in elderly patients, as they are more likely to have heart problems and age-related peripheral vascular diseases. Also, elderly patients using ophthalmic beta-blockers may have a higher risk of corneal sensitivity with the consequent risk of keratitis.

Use in patients with renal and/or hepatic impairment

Your doctor may adjust the dose of Elebloc if it is administered in combination with another beta-blocker medication.

Use in athletes

This medication contains carteolol, which may produce a positive result in doping tests.

Children and adolescents

This medication is not recommended for premature babies, newborns, children, or adolescents, as its safety and efficacy have not been established in the pediatric population.

Using Elebloc with other medications

Inform your doctor or pharmacist if you are using or have recently used or may need to use any other medication.

This medication may affect or be affected by other medications you are using, including other eye drops for glaucoma treatment. Consult your doctor if you are using or plan to use medications to lower blood pressure, such as parasymphathomimetics and guanethidine, amiodarone, or other medications to treat heart rhythm disorders, cardiac glycosides to treat heart failure, or medications to treat diabetes.

Pregnancy and breastfeeding

If you are pregnant, breastfeeding, or think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.

Do not use Elebloc if you are pregnant or think you may be pregnant, unless your doctor considers it necessary.

Do not use Elebloc if you are breastfeeding, as carteolol may pass into breast milk. However, if your doctor considers it necessary for the mother's benefit, they will assess the possibility of interrupting breastfeeding.

Consult your doctor before using any medication during breastfeeding.

Driving and using machines

After administering this medication, you may experience blurred vision. Do not drive or use machines until this effect has disappeared and your vision has cleared.

Elebloc contains benzalkonium chloride

This medication may cause eye irritation because it contains benzalkonium chloride. Avoid contact with soft contact lenses. Remove contact lenses before application and wait at least 15 minutes before putting them back. It may alter the color of soft contact lenses.

3. How to use Elebloc 20 mg/ml

Follow exactly the administration instructions of this medication indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.

The recommended dose is:

Adults (including elderly patients)

It is recommended to start treatment with the lowest available dose of carteolol. If the clinical response is not adequate, your doctor may modify the dose to one drop of Elebloc 20 mg/ml instilled twice a day (morning and evening) in each affected eye.

The daily dose should not exceed two drops in each affected eye.

Follow exactly the instructions given by your doctor. The eye pressure should be periodically checked, mainly during the dose adjustment period.

Instructions for use:

This medication should be administered in the eyes (ophthalmic route). If you need to use more than one medication via the ophthalmic route, the applications should be spaced at least 5 minutes apart. Ophthalmic ointments should be administered last.

Sequence of hands holding and applying an auto-injector device to the abdomen or thigh

1234

If you wear contact lenses, you should remove them before applying Elebloc and wait 15 minutes before putting them back.

  1. Wash your hands carefully before applying the drops.
  2. Take the bottle and stand in front of a mirror.
  3. After opening the bottle for the first time, you should remove the plastic ring from the seal.
  4. Hold the bottle, upside down, between your fingers (figure 1).
  5. Tilt your head back. Gently separate the eyelid from the eye with a finger until a pocket forms between the eyelid and your eye, where the drop should fall (figure 2).
  6. Bring the tip of the bottle close to the eye. You may find it helpful to use a mirror.
  7. Do not touch the eye or eyelid, nearby areas, or other surfaces with the dropper. The eye drop may become contaminated.
  8. Gently squeeze the base of the bottle to release one drop at a time (figure 3).
  9. After using Elebloc, press the edge of the eye next to the nose (figure 4) for 2 minutes. This helps prevent carteolol from entering the rest of the body.
  10. If you apply drops to both eyes, repeat all the previous steps with the other eye.
  11. Close the bottle tightly immediately after each use.

If a drop falls outside the eye, try again.

If you use more Elebloc than you should

If too many drops are administered in the eyes, rinse them with warm water or saline solution.

If you accidentally ingest the entire contents of the container, the expected symptoms may include slow heart rate, decreased blood pressure, breathing difficulties, and heart failure.

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medication and the amount ingested.

If you forget to use Elebloc

Apply a single dose as soon as possible. However, if it is almost time for the next dose, do not apply the missed dose and continue with the next dose of your regular regimen. Do not apply a double dose to make up for missed doses.

If you stop using Elebloc

Never stop treatment without consulting your doctor or pharmacist first.

If you have any other questions about using this medication, ask your doctor or pharmacist.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medications, Elebloc may cause side effects, although not everyone will experience them.

Generally, you can continue using the drops unless the effects are severe. If you are concerned, consult your doctor or pharmacist. Do not stop treatment with Elebloc without consulting your doctor first.

In some patients with significantly damaged corneas, very rare cases of corneal calcification related to the use of eye drops containing phosphates have been reported.

Like other ophthalmic medications applied to the eyes, carteolol is absorbed and enters the bloodstream. This may cause side effects similar to those observed with intravenous and/or oral beta-blocker medications. The incidence of these side effects after ophthalmic administration is lower than when medications are administered orally or injected. The adverse reactions described include reactions observed within the class of ophthalmic beta-blockers when used to treat eye diseases:

Allergic reactions:Systemic allergic reactions, including swelling under the skin, which can occur in the face and limbs, and can obstruct the airway and cause difficulty swallowing or breathing, hives, and skin rash with itching, localized and generalized rash, pruritus, severe and sudden life-threatening allergic reaction.

Metabolism:Low blood sugar levels.

Nervous system and general disorders:Difficulty sleeping (insomnia), depression, nightmares, memory loss, fainting, stroke, reduced blood supply to the brain, increased signs and symptoms of myasthenia gravis (muscle disorder), dizziness, abnormal sensations of tingling, like "pins and needles", headache, fatigue.

Eye effects:Signs and symptoms of eye irritation (such as burning, stinging, itching, tearing, redness), eyelid inflammation, corneal inflammation, blurred vision, detachment of the layer under the retina that contains blood vessels, which can cause vision changes after filtration surgery, decreased sensitivity in the eye, dry eyes, corneal erosion (the outer layer of the eyeball), drooping of the upper eyelids (causing the eye to remain half-closed), double vision, conjunctivitis.

Heart and circulation:Slow heart rate, chest pain, palpitations, edema (fluid accumulation), changes in heart rate or rhythm, congestive heart failure (heart disease with difficulty breathing and swelling of the feet and legs due to fluid accumulation), a type of heart rhythm disorder, cardiac arrest, heart failure, low blood pressure, Raynaud's disease, cold hands and feet.

Respiratory:Narrowing of the airways in the lungs (mainly in patients with pre-existing bronchospastic disease), difficulty breathing, coughing.

Gastrointestinal:Alteration of taste, nausea, indigestion, diarrhea, dry mouth, abdominal pain, vomiting.

Skin:Hair loss, skin rash with a silvery white appearance (psoriasiform rash) or worsening of psoriasis, skin rash.

Muscular:Muscle pain not caused by exercise, muscle weakness.

Reproductive:Sexual dysfunction, decreased libido.

Reporting side effects

If you experience any side effects, consult your doctor or pharmacist, even if they are possible side effects not listed in this package leaflet. You can also report them directly through the Spanish Medication Surveillance System for Human Use: https://www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medication.

5. Storage of Elebloc

Keep this medication out of the sight and reach of children.

Do not use this medication after the expiration date stated on the bottle and carton after "EXP:". The expiration date is the last day of the month indicated.

Do not store above 25°C.

To avoid infections, the bottle should be discarded 4 weeks after opening for the first time. Write the opening date of the bottle in the space provided on the carton for this purpose.

Medications should not be disposed of via wastewater or household waste. Deposit the containers and medications you no longer need at the SIGRE collection point in your pharmacy. If in doubt, ask your pharmacist how to dispose of the containers and medications you no longer need. This will help protect the environment.

6. Package contents and additional information

Composition of Elebloc

  • The active ingredient is carteolol hydrochloride. Each ml of solution contains 20 mg of carteolol hydrochloride.
  • The other components are benzalkonium chloride, sodium chloride, sodium phosphate monobasic, disodium hydrogen phosphate dodecahydrate, and purified water.

Appearance of the product and package contents

Elebloc is presented as a clear and colorless solution in a 5 ml plastic bottle with a cap.

Marketing authorization holder

Immedica Pharma AB

SE-113 63 Stockholm

Sweden

Manufacturer

Siegfried El Masnou, S.A.

C/Camil Fabra, 58

08320 El Masnou - Barcelona

Date of the last revision of this package leaflet: October 2016.

Detailed information about this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/

Online doctors for ELEBLOC 20 mg/ml EYE DROPS SOLUTION

Discuss questions about ELEBLOC 20 mg/ml EYE DROPS SOLUTION, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (69)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
5.0 (63)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Camera Book a video appointment
€59
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80

Frequently Asked Questions

Is a prescription required for ELEBLOC 20 mg/ml EYE DROPS SOLUTION?
ELEBLOC 20 mg/ml EYE DROPS SOLUTION requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in ELEBLOC 20 mg/ml EYE DROPS SOLUTION?
The active ingredient in ELEBLOC 20 mg/ml EYE DROPS SOLUTION is carteolol. This information helps identify medicines with the same composition but different brand names.
How much does ELEBLOC 20 mg/ml EYE DROPS SOLUTION cost in pharmacies?
The average pharmacy price for ELEBLOC 20 mg/ml EYE DROPS SOLUTION is around 3.17 EUR. Prices may vary depending on the manufacturer and dosage form.
Who manufactures ELEBLOC 20 mg/ml EYE DROPS SOLUTION?
ELEBLOC 20 mg/ml EYE DROPS SOLUTION is manufactured by Immedica Pharma Ab. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of ELEBLOC 20 mg/ml EYE DROPS SOLUTION online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether ELEBLOC 20 mg/ml EYE DROPS SOLUTION is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to ELEBLOC 20 mg/ml EYE DROPS SOLUTION?
Other medicines with the same active substance (carteolol) include ARTEOPTIC 1% PROLONGED-RELEASE EYE DROPS, ARTEOPTIC 2% PROLONGED-RELEASE EYE DROPS, ARTEOPTIC 20 mg/ml SINGLE-DOSE PROLONGED-RELEASE EYE DROPS IN SINGLE-DOSE PACKAGING. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media